These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24635554)

  • 1. A review of topically administered mini-tablets for drug delivery to the anterior segment of the eye.
    Moosa RM; Choonara YE; du Toit LC; Kumar P; Carmichael T; Tomar LK; Tyagi C; Pillay V
    J Pharm Pharmacol; 2014 Apr; 66(4):490-506. PubMed ID: 24635554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in ocular drug delivery.
    Rawas-Qalaji M; Williams CA
    Curr Eye Res; 2012 May; 37(5):345-56. PubMed ID: 22510004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anterior eye segment drug delivery systems: current treatments and future challenges.
    Molokhia SA; Thomas SC; Garff KJ; Mandell KJ; Wirostko BM
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):92-105. PubMed ID: 23485091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micelles: Promising Ocular Drug Carriers for Anterior and Posterior Segment Diseases.
    Durgun ME; Güngör S; Özsoy Y
    J Ocul Pharmacol Ther; 2020; 36(6):323-341. PubMed ID: 32310723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases.
    Choonara YE; Pillay V; Danckwerts MP; Carmichael TR; du Toit LC
    J Pharm Sci; 2010 May; 99(5):2219-39. PubMed ID: 19894268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled and continuous release ocular drug delivery systems: pros and cons.
    Abdelkader H; Alany RG
    Curr Drug Deliv; 2012 Jul; 9(4):421-30. PubMed ID: 22640036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mini-tablets: a contemporary system for oral drug delivery in targeted patient groups.
    Aleksovski A; Dreu R; Gašperlin M; Planinšek O
    Expert Opin Drug Deliv; 2015 Jan; 12(1):65-84. PubMed ID: 25200881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases.
    Onugwu AL; Nwagwu CS; Onugwu OS; Echezona AC; Agbo CP; Ihim SA; Emeh P; Nnamani PO; Attama AA; Khutoryanskiy VV
    J Control Release; 2023 Feb; 354():465-488. PubMed ID: 36642250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances in Topical Ocular Drug Delivery.
    Yellepeddi VK; Palakurthi S
    J Ocul Pharmacol Ther; 2016 Mar; 32(2):67-82. PubMed ID: 26666398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel strategies for anterior segment ocular drug delivery.
    Cholkar K; Patel SP; Vadlapudi AD; Mitra AK
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):106-23. PubMed ID: 23215539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular delivery systems for topical application of anti-infective agents.
    Duxfield L; Sultana R; Wang R; Englebretsen V; Deo S; Rupenthal ID; Al-Kassas R
    Drug Dev Ind Pharm; 2016 Jan; 42(1):1-11. PubMed ID: 26325119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient intraocular penetration of topical anti-TNF-alpha single-chain antibody (ESBA105) to anterior and posterior segment without penetration enhancer.
    Ottiger M; Thiel MA; Feige U; Lichtlen P; Urech DM
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):779-86. PubMed ID: 18757511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug delivery systems to target the anterior segment of the eye: fundamental bases and clinical applications].
    Behar-Cohen F
    J Fr Ophtalmol; 2002 May; 25(5):537-44. PubMed ID: 12048521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
    Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C
    Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in topical nano drug-delivery systems for the anterior ocular segment.
    Lakhani P; Patil A; Majumdar S
    Ther Deliv; 2018 Feb; 9(2):137-153. PubMed ID: 29325511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimally invasive microneedles for ocular drug delivery.
    Thakur Singh RR; Tekko I; McAvoy K; McMillan H; Jones D; Donnelly RF
    Expert Opin Drug Deliv; 2017 Apr; 14(4):525-537. PubMed ID: 27485251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical delivery of ocular therapeutics: carrier systems and physical methods.
    Souza JG; Dias K; Pereira TA; Bernardi DS; Lopez RF
    J Pharm Pharmacol; 2014 Apr; 66(4):507-30. PubMed ID: 24635555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-based intravesical drug delivery systems with controlled release of trospium chloride for the urinary bladder.
    Haupt M; Thommes M; Heidenreich A; Breitkreutz J
    J Control Release; 2013 Sep; 170(2):161-6. PubMed ID: 23732944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and future ophthalmic drug delivery systems. A shift to the posterior segment.
    Del Amo EM; Urtti A
    Drug Discov Today; 2008 Feb; 13(3-4):135-43. PubMed ID: 18275911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of combined-release behaviors from a novel "tablets-in-capsule system".
    Li YH; Zhu JB
    J Control Release; 2004 Mar; 95(3):381-9. PubMed ID: 15023450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.